Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002084 · ClinicalTrials.gov registry record · NA

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

A NA study of HIV Infections and Herpes Simplex, sponsored by Glaxo Wellcome.

Completed
Registry status
NA
Development phase
20
Study locations

NCT00002084 is a NA study of HIV Infections and Herpes Simplex that has completed, run by Glaxo Wellcome. The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002084, a NA study of HIV Infections and Herpes Simplex, has completed, sponsored by Glaxo Wellcome.

COMPLETED
Registry status
NA
Development phase
20
Study locations

Study Summary

To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with CD4 counts = or \> 100 cells/mm3.

Conditions Studied

HIV Infections Herpes Simplex

Interventions

  • DRUG Acyclovir
  • DRUG Valacyclovir hydrochloride

Study Locations (20)

California

  • Combat Group - Los Angeles
  • Los Angeles County - USC Med Ctr - Los Angeles
  • Infectious Disease Med Group / Adult Immunology Clinic - Oakland
  • UCI Med Ctr - Orange
  • UCSD Med Ctr - San Diego
  • San Diego Naval Hosp - San Diego
  • ViRx Inc - San Francisco
  • UCSF - San Francisco Gen Hosp - San Francisco
  • Dr Marcus Conant - San Francisco

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.
  • Whitman - Walker Clinic - Washington D.C.
  • George Washington Univ Med Ctr - Washington D.C.
  • Veterans Administration Med Ctr / Regional AIDS Program - Washington D.C.

Georgia

  • Emory Univ School of Medicine - Atlanta
  • AIDS Research Consortium of Atlanta - Atlanta

Alabama

  • Univ of South Alabama - Mobile

Arizona

  • Univ of Arizona / Health Science Ctr - Tucson

Connecticut

  • West Haven Veterans Administration Med Ctr - West Haven

Florida

  • Univ of South Florida - St. Petersburg

Illinois

  • Northwestern Memorial Hosp - Chicago

Trial Details

FieldValue
Phase NA

Sponsor

Glaxo Wellcome

65 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002084

The ClinicalTrials.gov registry entry for NCT00002084 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Glaxo Wellcome, which has 65 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Acyclovir is the first listed.

NCT00002084 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, District of Columbia, Georgia.

Frequently Asked Questions

What is clinical trial NCT00002084 about?

NCT00002084 is a clinical study titled "A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients". To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with CD4 counts = or \> 100 cells/mm3.

What is the current status of trial NCT00002084?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002084 study?

This clinical trial studies the following conditions: HIV Infections, Herpes Simplex.

What interventions are being tested in trial NCT00002084?

The interventions under investigation include: Acyclovir (DRUG), Valacyclovir hydrochloride (DRUG).

Who is sponsoring clinical trial NCT00002084?

This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002084 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Herpes Simplex

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.